Interferon-γ: an overview of signals, mechanisms and functions
The DOI matches its Crossref record; 433 of the 443 references it cites were found in a registry or an index.
Abstract
Interferon-γ (IFN-γ) coordinates a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes. This article reviews the current understanding of IFN-γ ligand, receptor, ignal transduction, and cellular effects with a focus on macrophage responses and to a lesser extent, responses from other cell types that influence macrophage function during infection. The current model for IFN-γ signal transduction is discussed, as well as signal regulation and factors conferring signal specificity. Cellular effects of IFN-γ are described, including up-regulation of pathogen recognition, antigen processing and presentation, the antiviral state, inhibition of cellular proliferation and effects on apoptosis, activation of microbicidal effector functions, immunomodulation, and leukocyte trafficking. In addition, integration of signaling and response with other cytokines and pathogen-associated molecular patterns, such as tumor necrosis factor-α, interleukin-4, type I IFNs, and lipopolysaccharide are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the proteins encoded by these genes are all reported to be part of a signaling cascade upstream of interferon regulatory factor 1 (IRF1) and downstream of interferon-γ (IFNγ; ref. 50).”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [50]
Citations
Cites
Items 201–400 of 433
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense
Salazar-Mather, T. P., Hamilton, T. A., & Biron, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9232 · Cited by 233
IFNs and STATs in innate immunity to microorganisms
Decker, T., Stockinger, S., Karaghiosoff, M., Müller, M. M., & Kovarik, P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15770 · Cited by 229 · cited 1×
“zymes promoting microbe destruction (Table 1) [222].”
Gao, J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., & Murphy, W. J. (1998) · PubMed · Cited by 225
Liew, F. Y., Li, Y., Severn, A., Millott, S., Schmidt, J., Salter, M., & Moncada, S. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211027 · Cited by 222
Interleukin‐4 and Interferon‐γ: The Quintessence of a Mutual Antagonistic Relationship
PALUDAN (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00435.x · Cited by 221 · cited 1×
“Transcription of many IFN- -responsive genes is controlled by a GAS element or an ISRE [108].”
Lehn, M., Weiser, W. Y., Engelhorn, S., Gillis, S., & Remold, H. G. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.3020 · Cited by 220
Ser727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation
Zhang, J. J., Zhao, Y., Chait, B. T., Lathem, W. W., Ritzi, M., Knippers, R., & Darnell, J. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6963 · Cited by 220
Igarashi, K., Garotta, G., Ozmen, L., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Larner, A. C., & Finbloom, D. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36621-8 · Cited by 218 · cited 1×
“The four critical tyrosines (contained by Jak1, Jak2, IFNGR1, and Stat1) are phosphorylated within 1 min of IFN- treatment [41, 99].”
Nussler, A. K., Billiar, T. R., Liu, Z. Z., & Morris, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42251-4 · Cited by 217 · cited 1×
“[282–284]”
Hou, J., Baichwal, V, & Cao, Z. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11641 · Cited by 217 · cited 1×
“[303]”
Ligand-Induced Autoregulation of IFN-γ Receptor β Chain Expression in T Helper Cell Subsets
Bach, E. A., Szabo, S. J., Dighe, A. S., Ashkenazi, A., Aguet, M., Murphy, K. M., & Schreiber, R. D. (1995) · Science · doi:10.1126/science.270.5239.1215 · Cited by 214
Hume, D. A. (2000) · Blood · doi:10.1182/blood.v96.7.2323 · Cited by 210
Self-citationCassatella, M. A., Bazzoni, F., Flynn, R. M., Dusi, S., Trinchieri, G., & Rossi, F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30495-7 · Cited by 204
Interferon-γ impacts at multiple points during the progression of autoimmune diabetes
Wang, B., André, I., Gonzalez, A., Katz, J. D., Aguet, M., Benoist, C., & Mathis, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13844 · Cited by 204 · cited 1×
“and insulin-dependent diabetes mellitus [82–84].”
A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1
Haspel, R. L., & Darnell, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10188 · Cited by 203 · cited 1×
“This model is supported by work from other groups, demonstrating Stat1 tyrosine dephosphorylation in the nucleus and subsequent recycling of inactive Stat1 to the cytoplasm, and is consistent with the crystal structure of Stat1 bound to DNA [137, 189, 192, 193].”
Pierre-Audigier, C., Jouanguy, E., Lamhamedi, S., Altare, F., Rauzier, J., Vincent, V., Canioni, D., Emile, J.-F., Fischer, A., Blanche, S., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.982 · Cited by 203 · cited 1×
“in childhood [63–71].”
Gao, J. J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., & Murphy, W. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4803 · Cited by 202
Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 201 · cited 1×
“Phosphorylation of S727 is necessary for interaction with some proteins, such as BRCA1 and MCM-5, and this interaction potentiates Stat1mediated transcription [128, 129].”
Schindler, H., Lutz, M. B., Röllinghoff, M., & Bogdan, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3075 · Cited by 201 · cited 2×
“Negative regulators of IFN- production include IL-4, IL10, transforming growth factor- , and glucocorticoids [17, 21, 27–29].”
Fukao, T., Frucht, D. M., Yap, G., Gadina, M., O’Shea, J. J., & Koyasu, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4446 · Cited by 199 · cited 1×
“In macrophages, NK and T cells, the combination of IL-12 and IL-18 stimulation further increases IFNproduction [20, 23, 24, 27, 28].”
Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor
McBride, K. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6196 · Cited by 196 · cited 3×
“[137] proposed a model in which nuclear export is mediated by a leucine-rich nuclear export signal (NES) at residues 197–205, which is hidden when Stat1 is bound to DNA.”
Regulation of transcription of MHC class II genes
Boss, J. M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80166-5 · Cited by 195
Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma.
Hisamatsu, H., Shimbara, N., Saito, Y., Kristensen, P., Hendil, K. B., Fujiwara, T., Takahashi, E., Tanahashi, N., Tamura, T., Ichihara, A., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1807 · Cited by 195 · cited 2×
“LMP-2 and LMP-7 map to class II MHC, and multicatalytic endopeptidase complex-like-1 (MECL-1) is encoded outside the MHC [210–216]”
Briscoe, J., Rogers, N. C., Witthuhn, B. A., Watling, D., Harpur, A. G., Wilks, A. F., Stark, G. R., Ihle, J. N., & Kerr, I. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00415.x · Cited by 194 · cited 1×
“The receptor-recruited Stat1 pair is phosphorylated near the C terminus at Y701, probably by Jak2 [98].”
Autenrieth, I. B., Beer, M., Bohn, E., Kaufmann, S. H., & Heesemann, J. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2590-2599.1994 · Cited by 191 · cited 1×
“Increased IFN- production in these strains is associated with greater resistance to bacteria and viruses [30–32].”
IFNs and STATs in innate immunity to microorganisms
Decker, T., Stockinger, S., Karaghiosoff, M., Müller, M., & Kovarik, P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215770 · Cited by 191
Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit
Nandi, D., Jiang, H., & Monaco, J. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2361 · Cited by 190 · cited 2×
“LMP-2 and LMP-7 map to class II MHC, and multicatalytic endopeptidase complex-like-1 (MECL-1) is encoded outside the MHC [210–216]”
Dependence of Peptide Binding by MHC Class I Molecules on Their Interaction with TAP
Grandea, A. G., Androlewicz, M. J., Athwal, R. S., Geraghty, D. E., & Spies, T. (1995) · Science · doi:10.1126/science.270.5233.105 · Cited by 184
Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S., & Biron, C. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4787 · Cited by 184 · cited 1×
“These chemokines attract NK cells to the site of inflammation, and IL-12 promotes IFN- synthesis in these cells [25, 26].”
Xaus, J., Cardó, M., Valledor, A. F., Soler, C., Lloberas, J., & Celada, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80085-0 · Cited by 182
Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth
BALKWILL, F., & TAYLOR-PAPADIMITRIOU, J. (1978) · Nature · doi:10.1038/274798a0 · Cited by 181
Cheshire, J. L., & Baldwin, A. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6746 · Cited by 178
Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1668 · Cited by 177 · cited 2×
“Overexpression of SOCS-1 in cells in vitro or in transgenic mice causes loss of responsiveness to IFN- [176, 179].”
Viral infections in interferon-γ receptor deficiency
Dorman, S. E., Uzel, G., Roesler, J., Bradley, J. S., Bastian, J., Billman, G., King, S., Filie, A., Schermerhorn, J., & Holland, S. M. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70064-8 · Cited by 177 · cited 1×
“bacterial and fungi pathogens have not been reported [72].”
Döffinger, R., Jouanguy, E., Dupuis, S., Fondanèche, M., Stephan, J., Emile, J., Lamhamedi‐Cherradi, S., Altare, F., Pallier, A., Barcenas‐Morales, G., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315197 · Cited by 177
Kubin, M., Chow, J., & Trinchieri, G. (1994) · Blood · doi:10.1182/blood.v83.7.1847.1847 · Cited by 176
Wong, A. H.-T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1291 · Cited by 175 · cited 1×
“implicated in numerous other functions, including activation of NF- B [243, 334], TNF- transcript splice regulation [244], induction of fas-mediated apoptosis [245, 246], and regulation of Stat1 activity [154, 247].”
Bliss, S. K., Marshall, A. J., Zhang, Y., & Denkers, E. (1999) · PubMed · Cited by 174
Yeung, M. C., Liu, J., & Lau, A. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12451 · Cited by 171 · cited 1×
“[270–272]”
Held, T. K., Weihua, X., Yuan, L., Kalvakolanu, D. V., & Cross, A. S. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.206-212.1999 · Cited by 171
The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor
Pestka, S., Kotenko, S. V., Muthukumaran, G., Izotova, L. S., Cook, J. R., & Garotta, G. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00009-9 · Cited by 170 · cited 1×
“Cross-linking experiments with labeled human IFN- demonstrated that IFN- only associates with IFNGR2 when the IFNGR1 chain is present, indicating that the primary interaction between the IFNGR2 chain and the IFN- :IFNGR1 complex is found between IFNGR1 and IFNGR2, although it is likely that IFNGR2 also interacts weakl…”
Thoreau, É., Petridou, B., Kelly, P. A., Djiane, J., & Mornon, J. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80437-8 · Cited by 170 · cited 1×
“It is likely that the IFNGR chains and other family members (type I IFN receptor and tissue factor) evolved from primitive adhesive molecules [33, 34].”
A third interferon‐γ‐induced subunit exchange in the 20S proteasome
Groettrup, M., Kraft, R., Kostka, S., Standera, S., Stohwasser, R., & Kloetzel, P. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260421 · Cited by 170
Singh, K., Balligand, J.-L., Fischer, T. A., Smith, T. W., & Kelly, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1111 · Cited by 168 · cited 1×
“Stat1 activation is necessary but not sufficient for transcription of a number of genes [125, 126].”
Cytosolic Tyrosine Dephosphorylation of STAT5
Yu, C.-L., Jin, Y.-J., & Burakoff, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.599 · Cited by 168
Krause, C. D., Mei, E., Xie, J., Jia, Y., Bopp, M. A., Hochstrasser, R. M., & Pestka, S. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200065-mcp200 · Cited by 168 · cited 1×
“The IFNGR1 and IFNGR2 subunits of the IFN- receptor were thought not to strongly associate with each other in the absence of ligand [13, 40, 47, 91, 92], but new techniques allowing the study of receptor chain interactions in intact cells have shown the receptor complex is assembled before ligand binding [93].”
IFN-γ Expression in Macrophages and Its Possible Biological Significance
Gessani, S., & Belardelli, F. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00007-0 · Cited by 166 · cited 4×
“The IFNGR1 and IFNGR2 subunits of the IFN- receptor were thought not to strongly associate with each other in the absence of ligand [13, 40, 47, 91, 92], but new techniques allowing the study of receptor chain interactions in intact cells have shown the receptor complex is assembled before ligand binding [93].”
InfluentialInteraction between the Components of the Interferon γ Receptor Complex
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Mariano, T. M., Donnelly, R. J., Muthukumaran, G., Cook, J. R., Garotta, G., Silvennoinen, O., Ihle, J. N., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20915 · Cited by 164 · cited 3×
“In humans, these sites are (263)PPSIP(267) and (270)IEEYL(274) [46, 47].”
Cytokine transcriptional events during helper T cell subset differentiation.
Lederer, J. A., Perez, V. L., DesRoches, L., Kim, S. M., Abbas, A. K., & Lichtman, A. H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.397 · Cited by 164
Pine, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4346 · Cited by 164 · cited 3×
“In many cases, synergistic induction by the combination of these factors may be a result of the combined presence of Stat1 and NF- B-binding sites in the promoter elements of responsive genes [160, 404].”
Shirayoshi, Y., Burke, P. A., Appella, E., & Ozato, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5884 · Cited by 162
Regulation of Interferon-γ Gene Expression
YOUNG, H. A. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.563 · Cited by 159
Jesse, T. L., LaChance, R., Iademarco, M. F., & Dean, D. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1265 · Cited by 159 · cited 1×
“[304]”
ISGF3γ p48, a specificity switch for interferon activated transcription factors
Bluyssen, H. A. R. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00005-6 · Cited by 158 · cited 1×
“, Stat1:Stat1:IRF-9, Stat1:Stat2:IRF-9) form during signaling [102, 116–118].”
Zhu, X., Wen, Z., Xu, L. Z., & Darnell, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6618 · Cited by 158
Patterson, J. B., Thomis, D. C., Hans, S. L., & Samuel, C. E. (1995) · Virology · doi:10.1006/viro.1995.1370 · Cited by 156
Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins
Belich, M. P., Glynne, R. J., Senger, G., Sheer, D., & Trowsdale, J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00174-3 · Cited by 155
Carlin, J. M., Borden, E. C., Sondel, P. M., & Byrne, G. I. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2414 · Cited by 154
Molecular Mechanisms Involved in Macrophage Survival, Proliferation, Activation or Apoptosis
Xaus, J., Comalada, M., Valledor, A. F., Cardó, M., Herrero, C., Soler, C., Lloberas, J., & Celada, A. (2001) · Immunobiology · doi:10.1078/0171-2985-00091 · Cited by 153
Bliss, S. K., Marshall, A. J., Zhang, Y., & Denkers, E. Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7369 · Cited by 152
Horvath, C. M., & Darnell, J. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.647-650.1996 · Cited by 151 · cited 1×
“Phosphorylation of Stat1 at S727 is essential for maximal ability to activate transcription of target genes [111–113, 120– 122].”
IRF-1: the transcription factor linking the interferon response and oncogenesis
Taniguchi, T., Lamphier, M. S., & Tanaka, N. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00014-0 · Cited by 150 · cited 1×
“Induction of apoptosis by signals such as DNA damage requires the IRF-1 tumor-suppressor gene [165, 266, 267].”
Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?
Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01251-2 · Cited by 147
Adib-Conquy, M., & Cavaillon, J.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200705200 · Cited by 146
Roesler, J., Kofink, B., Wendisch, J., Heyden, S., Paul, D., Friedrich, W., Casanova, J., Leupold, W., Gahr, M. L., & Rösen‐Wolff, A. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00077-6 · Cited by 146 · cited 1×
“in childhood [63–71].”
Lee, C.-K., Smith, E., Gimeno, R., Gertner, R., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1286 · Cited by 145 · cited 3×
“In the absence of IFN-induced tyrosine phosphorylation, Stat1 drives constitutive transcription of genes such as caspases [132, 133].”
Ligand-Induced Assembly and Activation of the Gamma Interferon Receptor in Intact Cells
Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., & Schreiber, R. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.3214 · Cited by 145 · cited 2×
“In humans, these sites are (263)PPSIP(267) and (270)IEEYL(274) [46, 47].”
Takizawa, T., Ohashi, K., & Nakanishi, Y. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8128-8132.1996 · Cited by 142 · cited 1×
“[270–272]”
Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.
Newburger, P. E., Ezekowitz, R. A., Whitney, C., Wright, J., & Orkin, S. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5215 · Cited by 140 · cited 2×
“[287, 288]”
Perussia, B., Dayton, E. T., Fanning, V, Thiagarajan, P., Hoxie, J., & Trinchieri, G. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.6.2058 · Cited by 140 · cited 1×
“IFN- orchestrates leukocyte attraction and directs growth, maturation, and differentiation of many cell types [2–4], in addition to enhancing natural killer (NK) cell activity [5] and regulating B cell functions such as immunoglobulin (Ig) production and class switching [4, 6].”
Rousset, F., Malefijt, R. W., Slierendregt, B., Aubry, J. P., Bonnefoy, J. Y., Defrance, T., Banchereau, J., & de Vries, J. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.8.2625 · Cited by 139
Gollob, J. A., Schnipper, C. P., Murphy, E. A., Ritz, J., & Frank, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4472 · Cited by 139 · cited 1×
“platelet-derived growth factor [110–112, 123, 124].”
Yoneyama, M., Suhara, W., Fukuhara, Y., Sato, M., Ozato, K., & Fujita, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021379 · Cited by 138 · cited 1×
“ISGF3 is able to induce expression of type I IFN, thereby further amplifying the response of IFN- / -induced genes [206, 207].”
Sakatsume, M., Igarashi, K.-I., Winestock, K. D., Garotta, G., Larner, A. C., & Finbloom, D. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17528 · Cited by 138
Hassanain, H. H., Chon, S. Y., & Gupta, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53504-3 · Cited by 135
Combined immunodeficiency with defective expression in MHC class II genes.
Griscelli, C., Lisowska‐Grospierre, B., & Mach, B. (1989) · PubMed · Cited by 134
Levy-Strumpf, N., Deiss, L. P., Berissi, H., & Kimchi, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1615 · Cited by 133 · cited 1×
“[273–276]”
Bernabei, P., Coccia, E. M., Rigamonti, L., Bosticardo, M., Forni, G., Pestka, S., Krause, C. D., Battistini, A., & Novelli, F. (2001) · PubMed · Cited by 133
Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice
Lu, B., Ebensperger, C., Dembic, Z., Wang, Y., Kvatyuk, M., Lu, T., Coffman, R. L., Pestka, S., & Rothman, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8233 · Cited by 132
Interferon treatment of NZB mice: accelerated progression of autoimmune disease
Heremans, H., Billiau, A., Colombatti, A., Hilgers, J., & Somer, P. D. (1978) · Infection and Immunity · doi:10.1128/iai.21.3.925-930.1978 · Cited by 128 · cited 1×
“76], it may contribute to autoimmune nephritis [77, 78].”
Role for Gamma Interferon in Control of Herpes Simplex Virus Type 1 Reactivation
Cantin, E., Tanamachi, B., & Openshaw, H. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3418-3423.1999 · Cited by 127
Bernabei, P., Coccia, E. M., Rigamonti, L., Bosticardo, M., Forni, G., Pestka, S., Krause, C. D., Battistini, A., & Novelli, F. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.950 · Cited by 127
Alpha Interferon Suppresses the Cyclin D3 and cdc25A Genes, Leading to a Reversible G 0 -Like Arrest
Tiefenbrun, N., Melamed, D., Levy, N., Resnitzky, D., Hoffmann, I., Reed, S. I., & Kimchi, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3934 · Cited by 126
IFN-γ Induces IL-12 mRNA Expression by a Murine Macrophage Cell Line, J774
Yoshida, A., Koide, Y., Uchijima, M., & Yoshida, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1122 · Cited by 123 · cited 3×
“IFN- induces IL-12 production in phagocytes [296] and inhibits IL-4 secretion by Th2 populations [39], which may further drive Th1 differentiation in vivo.”
Mandal, M., Bandyopadhyay, D., Goepfert, T. M., & Kumar, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201529 · Cited by 122
Strunk, R. C., Cole, F. S., Perlmutter, D. H., & Colten, H. R. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95732-7 · Cited by 120
Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice
Guidotti, L. G., McClary, H., Loudis, J. M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1247 · Cited by 120
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119 · cited 1×
“The physiological relevance of IRF-1 function in transcriptional control of IFN- -regulated genes is highlighted by IRF-1 KO mice, in which many genes are submaximally induced by IFN- when compared with their WT littermates [162, 163].”
Look, D. C., Pelletier, M. R., & Holtzman, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37060-6 · Cited by 118
Isolation of DAP3, a Novel Mediator of Interferon-γ-induced Cell Death
Kissil, J. L., Deiss, L. P., Bayewitch, M., Raveh, T., Khaspekov, G., & Kimchi, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27932 · Cited by 118
Lio, D., Scola, L., Crivello, A., Bonafè, M., Franceschi, C., Olivieri, F., Colonna‐Romano, G., Candore, G., & Caruso, C. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00198-x · Cited by 118
Caldenhoven, E., Coffer, P., Yuan, J., Van de Stolpe, A., Horn, F., Kruijer, W., & Van der Saag, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31942-7 · Cited by 117
Pearl, J. E., Saunders, B. M., Ehlers, S., Orme, I. M., & Cooper, A. M. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1819 · Cited by 117 · cited 1×
“However, these mice show deficiencies in natural resistance to bacterial, parasitic, and viral infections such as vaccinia virus, Theiler’s murine encephalomyelitis virus, Leishmania major, Toxoplasma gondii, Listeria monocytogenes, and several poorly virulent mycobacteria species [54–59].”
Toll-like receptors: lessons from knockout mice
Akira, S. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280551 · Cited by 117
Interleukin-12 gene expression after viral infection in the mouse
Coutelier, J. P., Van Broeck, J., & Wolf, S. F. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1955-1958.1995 · Cited by 116
Epperson, D. E., Arnold, D., Spies, T., Cresswell, P., Pober, J. S., & Johnson, D. R. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3297 · Cited by 115
Sangfelt, O., Erickson, S., Einhorn, S., & Grandér, D. (1997) · Oncogene · doi:10.1038/sj.onc.1200832 · Cited by 115
The double‐stranded RNA‐dependent protein kinase is also activated by heparin
HOVANESSIAN, A. G., & GALABRU, J. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb13360.x · Cited by 115
Jahnke, A., & P. Johnson, J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01130-3 · Cited by 115
Association of STATs with relatives and friends
Chatterjee‐Kishore, M., van den Akker, F., & Stark, G. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01709-2 · Cited by 115 · cited 2×
“[119]) and are likely to influence specificity of DNA binding and transactivator ability.”
Rhee, S. H., Jones, B. W., Toshchakov, V., Vogel, S. N., & Fenton, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208633200 · Cited by 115
Osman, F., Jarrous, N., Ben-Asouli, Y., & Kaempfer, R. (1999) · Genes & Development · doi:10.1101/gad.13.24.3280 · Cited by 115 · cited 1×
“implicated in numerous other functions, including activation of NF- B [243, 334], TNF- transcript splice regulation [244], induction of fas-mediated apoptosis [245, 246], and regulation of Stat1 activity [154, 247].”
Activation of the Transcription Factor ISGF3 by Interferon-gamma
Matsumoto, M., Tanaka, N., Harada, H., Kimura, T., Yokochi, T., Kitagawa, M., Schindler, C., & Taniguchi, T. (1999) · Biological Chemistry · doi:10.1515/bc.1999.087 · Cited by 110 · cited 2×
“It is now evident that type I IFN signals primarily through ISGF3 but also uses Stat1 homodimers and conversely, type II IFN signals primarily through Stat1 homodimers but also uses ISGF3 to activate transcription [116].”
Human interferon-gamma is internalized and degraded by cultured fibroblasts.
Anderson, P., Yip, Y. K., & Vilček, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32439-6 · Cited by 109 · cited 1×
“In many cell types, the IFNGR1 chain eventually recycles to the cell surface in its uncoupled, dephosphorylated form, and the ligand is degraded [45, 171, 172].”
The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes
Kern, I., Steimle, V., Siegrist, C.-A., & Mach, B. (1995) · International Immunology · doi:10.1093/intimm/7.8.1295 · Cited by 109 · cited 1×
“sins B, H, and L, lysosomal proteases implicated in production of antigenic peptides for class II MHC loading [240, 241]; and DM, a regulator of peptide accessibility to the peptide-binding cleft of class II MHC [235, 237].”
Chang, C., Hammer, J., Loh, J. E., Fodor, W. L., & Flavell, R. (1992) · Immunogenetics · doi:10.1007/bf00179793 · Cited by 109
Hobeika, A. C., Subramaniam, P. S., & Johnson, H. M. (1997) · Oncogene · doi:10.1038/sj.onc.1200939 · Cited by 107
Kamijo, R., Shapiro, D., Le, J., Huang, S., Aguet, M., & Vilcek, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6626 · Cited by 106
Identification of an Interferon-γ Receptor α Chain Sequence Required for JAK-1 Binding
Kaplan, D. H., Greenlund, A. C., Tanner, J. W., Shaw, A. S., & Schreiber, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.9 · Cited by 105
Subramaniam, P. S., Torres, B. A., & Johnson, H. M. (2001) · Cytokine · doi:10.1006/cyto.2001.0905 · Cited by 105 · cited 2×
“[90] proposed a model suggesting a function for intracellular ligand in Stat1 nuclear localization.”
Govoni, G. R., Vidal, S. M., Cellier, M. F., Lepage, P., Malo, D., & Gros, P. (1995) · Genomics · doi:10.1006/geno.1995.1002 · Cited by 104 · cited 1×
“[4, 290]”
Johnson, D. R., & Pober, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5183 · Cited by 102
Farrar, M. A., Campbell, J. D., & Schreiber, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11706 · Cited by 102
Interferon-gamma induces receptor dimerization in solution and on cells.
Greenlund, A. C., Schreiber, R. D., Goeddel, D. V., & Pennica, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46817-7 · Cited by 101 · cited 1×
“Biologically active IFN- is a noncovalent homodimer formed by the self-association of two mature polypeptides in an antiparallel orientation [94, 95] and thus binds IFNGR1 in 2:2 binding stoichiometry [47, 95–97].”
Molecular interactions in macrophage activation
Adams, D. O. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90298-3 · Cited by 101 · cited 1×
“Macrophage “activation”, broadly defined as “acquisition of competence to execute a complex function” [1], is among the first actions to occur in innate immunity to potential pathogens.”
IFN-γ Primes Macrophage Responses to Bacterial DNA
Sweet, M. J., Stacey, K. J., Kakuda, D. K., Markovich, D., & Hume, D. A. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.263 · Cited by 100
Self-citationErbe, D. V., Collins, J. E., Shen, L., Graziano, R. F., & Fanger, M. W. (1990) · Molecular Immunology · doi:10.1016/0161-5890(90)90060-d · Cited by 99 · cited 1×
“IFN- also promotes microbe destruction by augmenting surface expression of the high-affinity Fc RI on mononuclear phagocytes, thereby promoting antibody-dependent, cell-mediated cytotoxicity [291].”
Harvat, B. L., Seth, P. K., & Jetten, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201055 · Cited by 98 · cited 2×
“IFNs inhibit proliferation primarily by increasing protein levels of Ink4 and Cip/Kip CKIs [252–255, 343, 344].”
Novelli, F., Bernabei, P., Ozmen, L., Rigamonti, L., Allione, A., Pestka, S., Garotta, G., & Forni, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1935 · Cited by 97
Laha, T. T., Hawley, M., Rock, K. L., & Goldberg, A. L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00287-j · Cited by 97
Ruff, S. J., Chen, K., & Cohen, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1263 · Cited by 97 · cited 1×
“Aside from SOCS protein function, IFN- signal downregulation can occur by receptor and Jak dephosphorylation by the PTPs Shp1 and Shp2 [183–187].”
Farrar, M. A., Fernandez-Luna, J., & Schreiber, R. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55039-0 · Cited by 96
Fidler, I. J., Fogler, W. E., Kleinerman, E. S., & SAIKI, I. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.4289 · Cited by 95 · cited 1×
“essential for the full biological activity of IFN- [144–148].”
Ohmori, Y., & Hamilton, T. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.2204 · Cited by 95 · cited 1×
“IRF-1 functions are not limited to IFNsignaling; IFN- -independent activities in viral/bacterial infection, lymphocyte development, regulation of cell cycle, growth inhibition, apoptosis and tumor suppression have been reported [107, 123, 135, 159, 164–168].”
Västrik, I., Kaipainen, A., Penttilä, T. L., Lymboussakis, A., Alitalo, R., Parvinen, M., & Alitalo, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1197 · Cited by 95 · cited 1×
“[259–262]”
Fleckner, J., Martensen, P. M., Tolstrup, A. B., Kjeldgaard, N. O., & Justesen, J. (1995) · Cytokine · doi:10.1006/cyto.1995.1009 · Cited by 95
THE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivo
Burke, F., Knowles, R. G., East, N., & Balkwill, F. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600117 · Cited by 94
Marsters, S. A., Pennica, D., Bach, E., Schreiber, R. D., & Ashkenazi, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5401 · Cited by 93 · cited 1×
“The IFNGR1 and IFNGR2 subunits of the IFN- receptor were thought not to strongly associate with each other in the absence of ligand [13, 40, 47, 91, 92], but new techniques allowing the study of receptor chain interactions in intact cells have shown the receptor complex is assembled before ligand binding [93].”
Suzuki, R., Sakamoto, H., Yasukawa, H., Masuhara, M., Wakioka, T., Sasaki, A. T., Yuge, K., Komiya, S., Inoue, A., & Yoshimura, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202143 · Cited by 88 · cited 1×
“One of the most inducible targets of IFN- is a specific feedback inhibitor, SOCS-1, which associates with Jak1/2, interfering with tyrosine kinase activity and inhibiting downstream IFN- signaling [173–177].”
STAT1 from the cell membrane to the DNA
Lillemeier, B. F., Köster, M., & Kerr, I. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2508 · Cited by 88 · cited 3×
“Stat1 nuclear translocation does not appear to be a result of liberation from a cytoplasmic anchor or transport by the cellular cytoskeleton or microtubules [136].”
InfluentialOther Kinases Can Substitute for Jak2 in Signal Transduction by Interferon-γ
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., & Pestka, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17174 · Cited by 88 · cited 1×
“This indicates that other Jaks cannot functionally substitute for Jak2 in vivo, although Jak3 can substitute for Jak2 in vitro to produce Stat1 homodimers and activate transcription of class I major histomcompatibility complex (MHC) [199].”
Germline transcripts of the murine immunoglobulin γ2a gene: structure and induction by IFN-γ
Collins, J. T., & Dunnick, W. A. (1993) · International Immunology · doi:10.1093/intimm/5.8.885 · Cited by 88
Identification of IFN-γ-Producing Cells in IL-12/IL-18-Treated Mice
Otani, T., Nakamura, S., Toki, M., Motoda, R., Kurimoto, M., & Orita, K. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1589 · Cited by 87
Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity
Tannenbaum, C. S., & Hamilton, T. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0314 · Cited by 85 · cited 1×
“display compromised tumor rejection [85–87].”
Fujimoto, M., Naka, T., Nakagawa, R., Kawazoe, Y., Morita, Y., Tateishi, A., Okumura, K., Narazaki, M., & Kishimoto, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1799 · Cited by 82
Celada, A., & Schreiber, R. D. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.1.147 · Cited by 81 · cited 1×
“In many cell types, the IFNGR1 chain eventually recycles to the cell surface in its uncoupled, dephosphorylated form, and the ligand is degraded [45, 171, 172].”
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression
Waldburger, J., Masternak, K., Muhlethaler‐Mottet, A., Villard, J., Peretti, M., Landmann, S., & Reith, W. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17813.x · Cited by 81
Autocrine Secretion of Interferon γ Negatively Regulates Homing of Immature B Cells
Flaishon, L., Hershkoviz, R., Lantner, F., Lider, O., Alon, R., Levo, Y., Flavell, R. A., & Shachar, I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1381 · Cited by 81 · cited 1×
“[5, 12–16]).”
Block of a glioma cell line in S by interferon
Lundblad, D., & Lundgren, E. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910270604 · Cited by 80
Gessani, S., Belardelli, F., Pecorelli, A., Puddu, P., & Baglioni, C. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2785-2789.1989 · Cited by 79
Donzé, O., Dostie, J., & Sonenberg, N. (1999) · Virology · doi:10.1006/viro.1999.9618 · Cited by 78 · cited 1×
“implicated in numerous other functions, including activation of NF- B [243, 334], TNF- transcript splice regulation [244], induction of fas-mediated apoptosis [245, 246], and regulation of Stat1 activity [154, 247].”
Harvat, B. L., & Jetten, A. M. (1996) · PubMed · Cited by 76
Larkin, J., Johnson, H. M., & Subramaniam, P. S. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050044769 · Cited by 76 · cited 1×
“Another study tracked the cellular localization of components of the IFNGR complex following ligand exposure [150].”
Stoichiometry of interaction between interferon γ and its receptor
FOUNTOULAKIS, M., ZULAUF, M., LUSTIG, A., & GAROTTA, G. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17248.x · Cited by 76 · cited 1×
“Biologically active IFN- is a noncovalent homodimer formed by the self-association of two mature polypeptides in an antiparallel orientation [94, 95] and thus binds IFNGR1 in 2:2 binding stoichiometry [47, 95–97].”
Cassatella, M. A., Hartman, L., Perussia, B., & Trinchieri, G. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114054 · Cited by 76
Hibino, Y., Kumar, C. S., Mariano, T. M., Lai, D., & Pestka, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50588-9 · Cited by 75 · cited 1×
“A number of studies with chimeric receptors in which the intracellular, transmembrane, or extracellular domains were swapped between the human and murine IFNGR chains showed that species specificity in interactions of the ligand:receptor complex is restricted to the receptor extracellular domains [49–53].”
Regulation of STAT1 Nuclear Export by Jak1
Mowen, K., & David, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7273-7281.2000 · Cited by 75 · cited 2×
“This model is supported by work from other groups, demonstrating Stat1 tyrosine dephosphorylation in the nucleus and subsequent recycling of inactive Stat1 to the cytoplasm, and is consistent with the crystal structure of Stat1 bound to DNA [137, 189, 192, 193].”
Aggarwal, B. B., & Eessalu, T. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61065-8 · Cited by 74
Infections in IFNGR-1-Deficient Children
JOUANGUY, E., ALTARE, F., LAMHAMEDI-CHERRADI, S., & CASANOVA, J.-L. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.583 · Cited by 73 · cited 1×
“in childhood [63–71].”
Novel Cell Type–Specific Antiviral Mechanism of Interferon γ Action in Macrophages
Presti, R. M., Popkin, D. L., Connick, M., Paetzold, S., & Virgin, H. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.483 · Cited by 73
The Carboxyl Terminus of Interferon-γ Contains a Functional Polybasic Nuclear Localization Sequence
Subramaniam, P. S., Mujtaba, M. G., Paddy, M. R., & Johnson, H. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.403 · Cited by 72 · cited 2×
“Stat1 nuclear translocation is mediated by NPI-1 [135], and immunoprecipitation of Stat1 following IFN- treatment showed that IFN- , IFNGR1, Stat1, and NPI-1 form a complex at the nuclear pore during translocation [142, 143].”
Mita, Y., Dobashi, K., Shimizu, Y., Nakazawa, T., & Mori, M. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00241-3 · Cited by 71
Nuclear accumulation of interferon gamma.
Bader, T., & Weitzerbin, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11831 · Cited by 71 · cited 1×
“Nuclear accumulation of IFN- is apparent shortly after cellular exposure to IFN[140, 141].”
Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells.
Sancéau, J., Sondermeyer, P., Béranger, F., FALCOFF, R., & Vaquero, C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2906 · Cited by 71 · cited 1×
“essential for the full biological activity of IFN- [144–148].”
Kominsky, S. L., Johnson, H. M., Bryan, G. T., Tanabe, T., Hobeika, A. C., Subramaniam, P. S., & Torres, B. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202217 · Cited by 71 · cited 2×
“IFNs inhibit proliferation primarily by increasing protein levels of Ink4 and Cip/Kip CKIs [252–255, 343, 344].”
Haque, S. J., Wu, Q., Kammer, W., Friedrich, K., Smith, J. M., Kerr, I. M., Stark, G. R., & Williams, B. R. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8563 · Cited by 70
The control of interferon‐inducible gene expression
Kerr, I. M., & Stark, G. R. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80802-a · Cited by 69 · cited 1×
“The first wave of IFN- -induced transcription occurs within 15–30 min of IFN- treatment [107].”
Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins
Köster, M., & Hauser, H. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00149.x · Cited by 69 · cited 1×
“The nuclear membrane forms an efficient barrier to inactivated Stat1, and entry requires a gain of nuclear localization sequence (NLS) function [136–138].”
Kawahara, K., Gotoh, T., Oyadomari, S., Kajizono, M., Kuniyasu, A., Ohsawa, K., Imai, Y., Kohsaka, S., Nakayama, H., & Mori, M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00100-0 · Cited by 69
ROLE OF TYPE I INTERFERONS DURING MACROPHAGE ACTIVATION BY LIPOPOLYSACCHARIDE
Vadiveloo, P. K., Vairo, G., Hertzog, P. J., Kola, I., & Hamilton, J. A. (2000) · Cytokine · doi:10.1006/cyto.2000.0766 · Cited by 69
Self-citationRaveh, T., Hovanessian, A. G., Meurs, E. F., Sonenberg, N., & Kimchi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25479 · Cited by 68 · cited 3×
“result of PKR action [251].”
Lundell, D. J., Lunn, C. A., Dalgarno, D. C., Fossetta, J. D., Greenberg, R. M., Reim, R., Grace, M. J., & Narula, S. K. (1991) · Protein Engineering Design and Selection · doi:10.1093/protein/4.3.335 · Cited by 68 · cited 2×
“essential for the full biological activity of IFN- [144–148].”
Seliger, B., Schreiber, K., Delp, K., Meissner, M., Hammers, S., Reichert, T., Pawlischko, K., Tampé, R., & Huber, C. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057001039.x · Cited by 68 · cited 1×
“[4, 233]”
Inhibition of E2F-4/DP-1-stimulated transcription by p202
Choubey, D., & Gutterman, J. U. (1997) · Oncogene · doi:10.1038/sj.onc.1201184 · Cited by 68
Beretta, L., Gabbay, M., Berger, R., Hanash, S., & Sonenberg, N. (1996) · PubMed · Cited by 68
Association of polymorphism in the interferon ? gene with IDDM
Awata, T., Matsumoto, C., Urakami, T., Hagura, R., Amemiya, S., & Kanazawa, Y. (1994) · Diabetologia · doi:10.1007/bf00418381 · Cited by 67
Gupta, J. W., Kubin, M. Z., Hartman, L., Cassatella, M. A., & Trinchieri, G. (1992) · PubMed · Cited by 66
Mathiak, G., Grass, G., Herzmann, T., Luebke, T., Zetina, C. C., Boehm, S. A., Bohlen, H., Neville, L. F., & Hoelscher, A. H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703629 · Cited by 66
Karupiah, G., Chen, J.-H., Nathan, C. F., Mahalingam, S., & MacMicking, J. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7703-7706.1998 · Cited by 65
Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells.
Roos, G., Leanderson, T., & Lundgren, E. (1984) · PubMed · Cited by 65
Cultraro, C. M., Bino, T., & Segal, S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2353 · Cited by 65 · cited 1×
“[259–262]”
Complement Factor B Gene Regulation: Synergistic Effects of TNF-α and IFN-γ in Macrophages
Huang, Y., Krein, P. M., Muruve, D. A., & Winston, B. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2627 · Cited by 63
Lee, S. B., Mělková, Z., Yan, W., Williams, B. R. G., Hovanessian, A. G., & Estéban, M. (1993) · Virology · doi:10.1006/viro.1993.1048 · Cited by 61
Interferon inducibility of mammalian tryptophanyl-tRNA synthetase: new perspectives
Kisselev, L. L., Frolova, L. I., & Haenni, A. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90178-p · Cited by 61
Gibbs, V. C., Williams, S. R., Gray, P. W., Schreiber, R. D., Pennica, D., Rice, G. C., & Goeddel, D. V. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.5860-5866.1991 · Cited by 60 · cited 1×
“A number of studies with chimeric receptors in which the intracellular, transmembrane, or extracellular domains were swapped between the human and murine IFNGR chains showed that species specificity in interactions of the ligand:receptor complex is restricted to the receptor extracellular domains [49–53].”
Vestal, D. J., Gorbacheva, V., & Sen, G. C. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050198435 · Cited by 60 · cited 1×
“[61, 249, 250]”
Cook, J. R., Jung, V, Schwartz, B., Wang, P., & Pestka, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11317 · Cited by 58 · cited 1×
“Residues (441)DKPH(444) are responsible for the binding specificity of IFNGR1 and Stat1 [41, 43, 44].”
Hemmi, S., Merlin, G., & Aguet, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2737 · Cited by 56
Subramaniam, P. S., Larkin, J., Mujtaba, M. G., Walter, M. R., & Johnson, H. M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.15.2771 · Cited by 54
Cramer, L. A., Nelson, S. L., & Klemsz, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3190 · Cited by 52 · cited 2×
“LPS treatment following IFN- exposure increases the percentage of molecules phosphorylated on Y701 and S727 and subsequent Stat1 DNA-binding activity relative to IFN- treatment alone, thereby augmenting IFN- dependent, Stat1-mediated gene expression [123, 223].”
Anderson, S. L., Shen, T., Lou, J., Xing, L., Blachere, N. E., Srivastava, P. K., & Rubin, B. Y. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1565 · Cited by 52
Wang, M., Pober, J. S., & Johnson, D. R. (1998) · Circulation Research · doi:10.1161/01.res.83.8.815 · Cited by 52
Studies on the gene expression of several NADPH oxidase components
Cassatella, M. A., Bazzoni, F., Amezaga, M. A., & Rossi, F. (1991) · Biochemical Society Transactions · doi:10.1042/bst0190063 · Cited by 51
Kim, Y., Peyrol, S., So, C.-K., Boyd, C. D., & Csiszar, K. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2<181::aid-jcb3>3.0.co;2-d · Cited by 49
Kawakami, T., Matsumoto, M., Sato, M., Harada, H., Taniguchi, T., & Kitagawa, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01426-2 · Cited by 48 · cited 1×
“It is interesting that ISGF3 is able to induce expression of type I IFN, thereby further amplifying the response of IFN- / -induced genes [206, 207].”
Smith, M. R., Muegge, K., Keller, J. R., Kung, H., Young, H. A., & Durum, S. K. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1777 · Cited by 46
Major, A. S., & Cuff, C. F. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5968-5974.1996 · Cited by 45 · cited 1×
“Increased IFN- production in these strains is associated with greater resistance to bacteria and viruses [30–32].”
Michishita, M., Yoshida, Y., Uchino, H., & Nagata, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38952-5 · Cited by 42
Figueiredo, F., Koerner, T. J., & Adams, D. O. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.11.3781 · Cited by 42 · cited 2×
“[234–237]”
Subramaniam, P. S., Green, M. M., Larkin, J., Torres, B. A., & Johnson, H. M. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001753289569 · Cited by 42 · cited 1×
“A deletion mutant of the putative NLS in human IFN- is still able to bind with high affinity to the IFNGR1 chain, but induction of biological response is absent [149].”
Interferon-γ polymorphisms in systemic lupus erythematosus
Lee, J., GOLDMAN, D. W., Piliero, L. M., Petri, M., & Sullivan, K. E. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363775 · Cited by 41
Regulation of Complement Protein Biosynthesis in Mononuclear Phagocytes
Colten, H. R., Perlmutter, R. C., Schlessinger, D., & Cole, F. S. (1986) · Novartis Foundation symposium · doi:10.1002/9780470720998.ch10 · Cited by 40 · cited 1×
“[292–294]”
HISSONG, B. D., & CARLIN, J. M. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.387 · Cited by 40
Cook, J. R., Emanuel, S. L., DONNELLY, R. J., Soh, J., Mariano, T. M., Schwartz, B., Rhee, S., & Pestka, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37475-6 · Cited by 38 · cited 1×
“IRF-1 functions are not limited to IFNsignaling; IFN- -independent activities in viral/bacterial infection, lymphocyte development, regulation of cell cycle, growth inhibition, apoptosis and tumor suppression have been reported [107, 123, 135, 159, 164–168].”
Tannenbaum, C. S., Major, J. A., & Hamilton, T. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.12.6833 · Cited by 38
Direct stimulation of macrophages by IL-12 and IL-18 — a bridge too far?
Gołąb, J., Zagożdżon, R., Stokłosa, T., Kamiński, R., Kozar, K., & Jakóbisiak, M. (2000) · Immunology Letters · doi:10.1016/s0165-2478(00)00178-4 · Cited by 38
Transport of γ-interferon into the cell nucleus may be mediated by nuclear membrane receptors
MacDonald, H. S., Kushnaryov, V. M., SEDMAK, J. J., & Grossberg, S. E. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90273-1 · Cited by 37 · cited 1×
“Nuclear accumulation of IFN- is apparent shortly after cellular exposure to IFN[140, 141].”
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1997) · PubMed · Cited by 37
IFN-γ increases cathepsin H mRNA levels in mouse macrophages
Lafuse, W. P., Brown, D., Castle, L., & Zwilling, B. S. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.4.663 · Cited by 37
Scheurich, P., Krönke, M., Schlüter, C., Üçer, U., & Pfizenmaier, K. (1986) · Immunobiology · doi:10.1016/s0171-2985(86)80111-5 · Cited by 35 · cited 2×
“[4, 224–231]”
Research works printed but not linked: 1
- Dey, 1999, Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis, J. Cell. Biochem., 72, 232, 10.1002/(sici)1097-4644(19990201)72:2<232::aid-jcb7>3.0.co;2-0 · DOI
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
“The activated dimers then accumulate in the nucleus to act as transcription factors (Schroder et al., 2004; Aaronson and Horvath, 2002).”
Role of cytokines in intervertebral disc degeneration: pain and disc content
Risbud, M. V., & Shapiro, I. M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.160 · Cited by 1,767
Metadata
- Authors
- Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A.
- Affiliations
- The University of Queensland (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Hume, David A
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-02
- Volume
- 75
- Issue
- 2
- Pages
- 163-189
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167017590
- Cited by
- 4,120
- References
- 443
- Citations by year
- 2026: 141 · 2025: 166 · 2024: 208 · 2023: 231 · 2022: 229 · 2021: 252 · 2020: 243 · 2019: 213 · 2018: 193 · 2017: 225 · 2016: 236 · 2015: 246 · 2014: 209 · 2013: 224 · 2012: 195
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon-gamma, IFN-gamma receptor, signal transduction, macrophage response, transcriptional regulation, antigen processing and presentation, antiviral state, apoptosis, immunomodulation, leukocyte migration, cytokine signaling, pathogen-associated molecular patterns
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Interferon-gamma, Macrophages, Signal Transduction, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.